Farallon presses Astellas to cut costs and overhaul drugs research in latest shareholder campaign gripping Tokyo ...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
M&A markets don't like volatility and unpredictability, and what we've seen in the past few weeks is the opposite of that,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback